Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O6-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance
2010 ◽
Vol 79
(11)
◽
pp. 1553-1561
◽
Raymond P. Baumann
◽
Philip G. Penketh
◽
Kimiko Ishiguro
◽
Krishnamurthy Shyam
◽
Yong L. Zhu
◽
...
2002 ◽
Vol 3
(4)
◽
pp. 297-309
◽
Randal Berg
◽
Peter Ferguson
◽
Janice DeMoor
◽
Mark Vincent
◽
James Koropatnick
1991 ◽
Vol 43
(2-3)
◽
pp. 604
Daniel Lemkuil
◽
David Nettesheim
◽
Asima Pattanaik
◽
C.Frank Shaw
◽
David H. Petering
1998 ◽
Vol 56
(3)
◽
pp. 345-349
◽
Dale R. Grabowski
◽
George R. Dubyak
◽
Lisa Rybicki
◽
Hiroyoshi Hidaka
◽
Ram Ganapathi
2017 ◽
Vol 9
(26)
◽
pp. 9190-9201
◽
Jibin Guan
◽
Jin Sun
◽
Feilong Sun
◽
Bo Lou
◽
Dong Zhang
◽
...
2002 ◽
Vol 8
(3)
◽
pp. 274-281
◽
Heidi LeBlanc
◽
David Lawrence
◽
Eugene Varfolomeev
◽
Klara Totpal
◽
John Morlan
◽
...
1986 ◽
Vol 99
(1)
◽
pp. 241-256
◽
Marvin Fishman
◽
Gary Gunther
2002 ◽
Vol 21
(34)
◽
pp. 5213-5223
◽
Emilio Fiore
◽
Carlo Fusco
◽
Pedro Romero
◽
Ivan Stamenkovic
2006 ◽
Vol 120
(3)
◽
pp. 297-309
◽
Sara Huerta-Yepez
◽
Mario Vega
◽
Hermes Garban
◽
Benjamin Bonavida
1991 ◽
Vol 13
(2-3)
◽
pp. 251-257
◽
James A. Blank
◽
Ronald L. Joiner
◽
David P. Houchens
◽
Garrett S. Dill
◽
David W. Hobson